Emcure Pharmaceuticals Q1 FY27 reports 22.8% revenue growth to ₹25,804 million, while PAT jumps 36.2% and EBITDA rises 25.8% in Q1 FY27.
Read MoreFY27 Earnings
MHRIL Q1 FY27 Results: Deferred Revenue at ₹5,825 Crore, 5,865 Keys Across 111 Resorts
MHRIL Q1 FY27: Mahindra Holidays reports 5% YoY consolidated revenue growth, 22% rise in sales value, and 10% growth in resort revenue.
Read More